HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A megalin polymorphism associated with promoter activity and Alzheimer's disease risk.

Abstract
Elevated cerebral levels of amyloid beta-protein (Abeta) occur in Alzheimer's disease (AD), yet only a few patients show evidence of increased Abeta production. This observation suggests that many, perhaps most, cases of AD are caused by faulty clearance of Abeta. Megalin, which plays an important role in mediating Abeta clearance, is an attractive candidate gene for genetic association with AD. To investigate this hypothesis, we analyzed the megalin gene in a population of 2,183 subjects. Genetic analysis indicated that the rs3755166 (G/A) polymorphism located in the megalin promoter associated with risk for AD, dependently of apolipoprotein E genotype. The rs3755166 AA genotype frequency was significantly greater in AD patients than in control subjects. Furthermore, the luciferase reporter assay indicated that the rs3755166 A variant has 20% less transcriptional activity than the rs3755166 G variant. This study provides strong evidence that this megalin polymorphism confers a greater risk for AD, and supports a biological role for megalin in the neurodegenerative processes involved in AD.
AuthorsTeo Vargas, Maria Jesus Bullido, Ana Martinez-Garcia, Desiree Antequera, Jordi Clarimon, Marcel Rosich-Estrago, Angeles Martin-Requero, Ignacio Mateo, Eloy Rodriguez-Rodriguez, Elisabet Vilella-Cuadrada, Ana Frank, Alberto Lleo, Laura Molina-Porcel, Rafael Blesa, Onofre Combarros, Teresa Gomez-Isla, Felix Bermejo-Pareja, Fernando Valdivieso, Eva Carro
JournalAmerican journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics (Am J Med Genet B Neuropsychiatr Genet) Vol. 153B Issue 4 Pg. 895-902 (Jun 05 2010) ISSN: 1552-485X [Electronic] United States
PMID20052685 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Amyloid beta-Peptides
  • Apolipoproteins E
  • Low Density Lipoprotein Receptor-Related Protein-2
Topics
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease (genetics, immunology)
  • Amyloid beta-Peptides (genetics, immunology)
  • Apolipoproteins E (genetics, immunology)
  • Case-Control Studies
  • Female
  • Genes
  • Genotype
  • Humans
  • Low Density Lipoprotein Receptor-Related Protein-2 (genetics, immunology)
  • Male
  • Multicenter Studies as Topic
  • Polymorphism, Genetic
  • Regulatory Sequences, Nucleic Acid
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: